Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masanori Matsumoto

Showing results (1-10 of 258) with videos related to

Pageof 26
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[Diagnosis and management of thrombotic microangiopathies]Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
New developments in treatment modalities of thrombotic thrombocytopenic purpuraMasanori Matsumoto
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 1, 2013
[anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura]Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 12, 2021
[Pathogenesis and novel treatment of thrombotic thrombocytopenic purpura]Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 29, 2023
[Novel treatment strategies for acquired thrombotic thrombocytopenic purpura]Masanori Matsumoto
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2013
[Role of STIM-dependent Ca(2+) influx in regulatory B cells]Masanori Matsumoto, Yoshihiro Baba
Journal of Clinical Medicine|May 27, 2023
Clinical Manifestations, Current and Future Therapy, and Long-Term Outcomes in Congenital Thrombotic Thrombocytopenic PurpuraKazuya Sakai, Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2020
[Acquired von Willebrand syndrome]Masaki Hayakawa, Masanori Matsumoto
Internal Medicine (Tokyo, Japan)|January 5, 2010
Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008Yoshihiro Fujimura, Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 6, 2022
[Development of a novel aptamer blocking the interaction between the VWF A1 domain and platelet GP Ib for the treatment of arterial thrombosis]Masanori Matsumoto, Kaori Harada
Pageof 26

Showing results (1-10 of 258) with videos related to

Sort By:
Pageof 26
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[Diagnosis and management of thrombotic microangiopathies]Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
New developments in treatment modalities of thrombotic thrombocytopenic purpuraMasanori Matsumoto
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 1, 2013
[anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura]Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 12, 2021
[Pathogenesis and novel treatment of thrombotic thrombocytopenic purpura]Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 29, 2023
[Novel treatment strategies for acquired thrombotic thrombocytopenic purpura]Masanori Matsumoto
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2013
[Role of STIM-dependent Ca(2+) influx in regulatory B cells]Masanori Matsumoto, Yoshihiro Baba
Journal of Clinical Medicine|May 27, 2023
Clinical Manifestations, Current and Future Therapy, and Long-Term Outcomes in Congenital Thrombotic Thrombocytopenic PurpuraKazuya Sakai, Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2020
[Acquired von Willebrand syndrome]Masaki Hayakawa, Masanori Matsumoto
Internal Medicine (Tokyo, Japan)|January 5, 2010
Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008Yoshihiro Fujimura, Masanori Matsumoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 6, 2022
[Development of a novel aptamer blocking the interaction between the VWF A1 domain and platelet GP Ib for the treatment of arterial thrombosis]Masanori Matsumoto, Kaori Harada
Pageof 26